ÐÓ°ÉÊÓÆµ

Skip to main content

Case Comprehensive Cancer Center

An external shot of building architecture
Hero Type
Image
Rose Lands $1.5M for Informatics Tool to Integrate Place-Contextualized Patient-Level Cancer Data
Johnie Rose, MD, PhD, member of Case CCC's Population and Cancer Prevention Program and Director of CWRU SOM's Preventive Medicine Residency Program, has received a $1.5M award from the National Cancer Institute to develop a first-of-its-kind, transportable informatics tool that will integrate patie...
dna-feat
Hero Type
Image
ÐÓ°ÉÊÓÆµ awarded $1.9M federal grant to develop technology to better understand genome data
Research could lead to new discoveries in cancer medicine With a new five-year, $1.9 million grant from the National Institute of General Medical Sciences (NIGMS), researchers at ÐÓ°ÉÊÓÆµ will develop computer software to analyze and interpret complex genome data. Analyzing ...
colorectal-cancer-feat
Hero Type
Image
Researchers awarded $1.14M to use artificial intelligence to determine best rectal cancer treatment strategy
With a new four-year, $1.14 million grant from the U.S. Department of Veterans Affairs, researchers at ÐÓ°ÉÊÓÆµ and the Louis Stokes Cleveland VA Medical Center, will use artificial intelligence (AI) to determine the best personalized treatment for veterans with rectal cancer....
east-palestine-welcome-feat
Hero Type
Image
Spartans Step Up: Healthy Futures Research Project
The Alumni Association of ÐÓ°ÉÊÓÆµ will host the next installment of Spartans Step Up, a webcast series focusing on topical issues and the CWRU community, Wednesday, Sept. 18, from 1 to 2 p.m. Gary Schwartz, director of the Case Comprehensive Cancer Center and vice dean of on...
Charis-Eng
Hero Type
Image
Remembering genetics pioneer, professor Charis Eng
At 4 years old, Charis Eng was captivated by her uncle’s career as a physician—an early fascination that wound up shaping her future. By age 16, she had already enrolled at the University of Chicago, marking the start of a journey that would eventually lead her to become a pioneering figure in medic...
Plow and Sossey-Alaoui Find Possible Therapeutic Target for Prostate Cancer Treatment
A study published in Nature's Scientific Reports by Case CCC Molecular Oncology Program members Edward Plow, PhD, and Khalid Sossey-Alaoui, PhD, suggests that Kindlin-2 should be closely examined as a therapeutic target for prostate cancer treatment. Titled Role of Kindlin 2 in prostate cancer, the...
Case CCC Mourns the Loss of Pioneering Scientists Robert Salata and Charis Eng
Robert Salata, MD, member of Case CCC's Population and Cancer Prevention Program, leading figure in the field of infectious diseases, and dedicated advocate for public health, passed away this week. His distinguished career at CWRU and University Hospitals spanned decades, during which he mentored g...
NPR's Morning Edition Features Team's Research on Obesity, Cancer, and GLP1s
Hsin-Ti (Cindy) Lin, MD, and Benjamin Liu, MD, both Residents at MetroHealth, were interviewed by National Public Radio's (NPR) health correspondent, Yuki Noguchi, about their research on the promise of GLP-1 agonists, a class of drugs now being used to treat diabetes and weight loss, for use in pre...
Parameswaran Passes the Torch to Metheny for New Trial Exploring BAFF CAR T-cell Therapy for Relapsed Myeloma
January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by these cells against mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. This app...
Nurse, Advocate, Activist, and Friend to Case CCC: Faye Gary Receives Lifetime Honor
If you haven't met Faye Gary, EdD, RN, FAAN, you should. A tiny bundle of energy, she exudes compassion while commanding a room of high schoolers or an auditorium of her peers. She rarely takes "no" for an answer, and she gets things done. Gary, a CWRU Distinguished University Professor, is one of ...